Genetics and pharmacogenomics of diffuse gliomas
作者： H.F. van Thuijl , B. Ylstra , T. Würdinger , D. van Nieuwenhuizen , J.J. Heimans
DOI: 10.1016/J.PHARMTHERA.2012.09.002
关键词:
摘要: Rapidly evolving techniques for analysis of the genome provide new opportunities cancer therapy. For diffuse gliomas this has resulted in molecular markers with potential personalized Some drugs that utilize pharmacogenomics are currently being tested clinical trials. In melanoma, lung-, breast-, gastric- and colorectal carcinoma several already clinically implemented diagnosis treatment. These insights can serve as a background promise limitations gliomas. Better characterization gliomas, including underpinnings drug efficacy trials, is urgently needed. We foresee exciting developments upcoming years benefit patients.
ru.nl
core.ac.uk
vumc.nl
elsevier.com
sci-hub.se 参考文章(132)
Kenneth D. Aldape, Karla Ballman, Alfred Furth, Jan. C. Buckner, Caterina Giannini, Peter C. Burger, Bernd W. Scheithauer, Robert B. Jenkins, C. David James, Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance. Journal of Neuropathology and Experimental Neurology. ,vol. 63, pp. 700- 707 ,(2004) , 10.1093/JNEN/63.7.700
Heikki Joensuu, Treatment of inoperable gastrointestinal stromal tumor (GIST) with Imatinib (Glivec, Gleevec). Medizinische Klinik. pp. 28- 30 ,(2002)
Craig Horbinski, Marina N. Nikiforova, Jonathan Hobbs, Stephanie Bortoluzzi, Kathleen Cieply, Sanja Dacic, Ronald L. Hamilton, The importance of 10q status in an outcomes-based comparison between 1p/19q fluorescence in situ hybridization and polymerase chain reaction-based microsatellite loss of heterozygosity analysis of oligodendrogliomas. Journal of Neuropathology and Experimental Neurology. ,vol. 71, pp. 73- 82 ,(2012) , 10.1097/NEN.0B013E318240FA65
Antoine M. Snijders, Norma Nowak, Richard Segraves, Stephanie Blackwood, Nils Brown, Jeffrey Conroy, Greg Hamilton, Anna Katherine Hindle, Bing Huey, Karen Kimura, Sindy Law, Ken Myambo, Joel Palmer, Bauke Ylstra, Jingzhu Pearl Yue, Joe W. Gray, Ajay N. Jain, Daniel Pinkel, Donna G. Albertson, Assembly of microarrays for genome-wide measurement of DNA copy number. Nature Genetics. ,vol. 29, pp. 263- 264 ,(2001) , 10.1038/NG754
Koichi Ichimura, Helena M. Goike, Bo R. Nilsson, Lu Liu, Esther E. Schmidt, V. Peter Collins, L. Magnus Bäcklund, Short Postoperative Survival for Glioblastoma Patients with a Dysfunctional Rb1 Pathway in Combination with No Wild-type PTEN Clinical Cancer Research. ,vol. 9, pp. 4151- 4158 ,(2003)
Bastian Malzkorn, Marietta Wolter, Markus J. Riemenschneider, Guido Reifenberger, Unraveling the glioma epigenome: from molecular mechanisms to novel biomarkers and therapeutic targets. Brain Pathology. ,vol. 21, pp. 619- 632 ,(2011) , 10.1111/J.1750-3639.2011.00536.X
Natalie Schmidt, Sonja Windmann, Guido Reifenberger, Markus J. Riemenschneider, DNA Hypermethylation and Histone Modifications Downregulate the Candidate Tumor Suppressor Gene RRP22 on 22q12 in Human Gliomas Brain Pathology. ,vol. 22, pp. 17- 25 ,(2012) , 10.1111/J.1750-3639.2011.00507.X
Ahmed Idbaih, Emmanuelle Crinière, Keith L. Ligon, Olivier Delattre, Jean-Yves Delattre, Array-Based Genomics in Glioma Research Brain Pathology. ,vol. 20, pp. 28- 38 ,(2010) , 10.1111/J.1750-3639.2009.00274.X
K Ichimura, Maria Bondesson Bolin, Helena M Goike, Esther E Schmidt, Ahmad Moshref, V Peter Collins, Deregulation of the p14ARF/MDM2/p53 Pathway Is a Prerequisite for Human Astrocytic Gliomas with G1-S Transition Control Gene Abnormalities Cancer Research. ,vol. 60, pp. 417- 424 ,(2000)
Munir Pirmohamed, Pharmacogenetics and pharmacogenomics British Journal of Clinical Pharmacology. ,vol. 52, pp. 345- 347 ,(2001) , 10.1046/J.0306-5251.2001.01498.X